Equipping Clinicians to Manage and Overcome Potential Complications of CAR T-Cell Therapy

Download All
Review the latest multidisciplinary guidance on monitoring and managing toxicities associated with CAR T-cell therapy. This comprehensive program features an expert-authored commentary and MedicalMinute slide/audio presentations, a pocket guide, and an updated online Interactive Decision Support Tool.
Caron A. Jacobson, MD


How can we safely administer CAR T-cell therapy to patients during the COVID-19 pandemic? In this commentary, I share strategies from my practice.

Caron A. Jacobson, MD Released: March 31, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Kite Pharma

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings